HIGHLIGHTS
- who: Danpeng Shen and colleagues from the Capital Medical University, China have published the research work: Pre-clinical efficacy evaluation of human umbilical cord mesenchymal stem cells for ischemic stroke, in the Journal: (JOURNAL)
- what: The authors explored the underlying mechanism of injecting hUCMSCs at the acute phase of the disease and the time windows, as well as the dose-effect relationship of the injeciton at the acute, subacute, and sequelae phases of the disease.
- how: The results showed that hUCMSCs could also successfully transdifferentiate into adipocytes (analyzed by Oil Red O staining . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.